iBio, Inc. (IBIO) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 119 transactions totaling $110.3M, demonstrating a bearish sentiment with -$89.0M in net insider flow. The most recent transaction on Jan 28, 2026 involved a transaction of 479,000 shares valued at $0.
No significant insider buying has been recorded for IBIO in the recent period.
No significant insider selling has been recorded for IBIO in the recent period.
Based on recent SEC filings, insider sentiment for IBIO is bearish with an Insider Alignment Score of 10/100 and a net flow of -$89.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at iBio, Inc. (IBIO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading IBIO stock, having executed 119 transactions in the past 90 days. The most active insider is Services Ltd. Portfolio (Executive), who has made 6 transactions totaling $87.7M.
Get notified when executives and directors at IBIO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 28, 2026 | Brenner Martin | Executive | Award | 479,000 | $N/A | $0 | |
| Jan 28, 2026 | Duran Felipe | Chief Financial Officer | Award | 179,000 | $N/A | $0 | C-Suite |
| Jan 28, 2026 | Banjak Marc | Chief Legal Officer | Award | 146,000 | $N/A | $0 | |
| Nov 1, 2023 | Brenner Martin | Executive | Sale | 4,881 | $0.27 | $1.3K | |
| Oct 3, 2023 | Brenner Martin | Executive | Sale | 5,267 | $0.30 | $1.6K | |
| Oct 2, 2023 | Brenner Martin | Executive | Sale | 4,215 | $0.31 | $1.3K | |
| Aug 28, 2023 | Brenner Martin | Executive | Sale | 5,011 | $0.31 | $1.6K | |
| Jul 27, 2023 | Brenner Martin | Executive | Sale | 4,480 | $0.51 | $2.3K | |
| Jul 27, 2023 | Brenner Martin | Executive | Sale | 35 | $0.51 | $18 | |
| Jul 12, 2023 | Brenner Martin | Executive | Sale | 47,020 | $0.59 | $27.7K | |
| Jun 26, 2023 | Brenner Martin | Executive | Award | 75,833 | $N/A | $0 | |
| Jun 22, 2023 | Brenner Martin | Executive | Disposition | 75,833 | $N/A | $0 | |
| Jun 21, 2023 | Brenner Martin | Executive | Sale | 100 | $0.68 | $68 | |
| Jun 21, 2023 | Brenner Martin | Executive | Sale | 225 | $0.69 | $155 | |
| Jun 21, 2023 | Brenner Martin | Executive | Sale | 3,859 | $0.68 | $2.6K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 87 | $99.7M | 82.9% |
Purchase(P) | 8 | $10.7M | 8.9% |
Conversion(C) | 2 | $5.8M | 4.8% |
Other(O) | 1 | $3.0M | 2.5% |
Exercise (Options)(X) | 2 | $962.7K | 0.8% |
Exercise(M) | 3 | $126.1K | 0.1% |
Award(A) | 11 | $0 | 0.0% |
Disposition(D) | 1 | $0 | 0.0% |
Other(J) | 4 | $0 | 0.0% |
Insider selling pressure at iBio, Inc. has increased, with 14 insiders executing 119 transactions across all time. Total sales of $99.7M significantly outpace purchases of $10.7M, resulting in a net outflow of $89.0M. This selling activity appears largely discretionary, which may warrant closer attention from investors.